Navigation Links
Nastech Announces Promotion of Gordon Brandt, M.D. to President
Date:12/20/2007

BOTHELL, Wash., Dec. 20 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that it has promoted Gordon Brandt, M.D. to President of Nastech. Dr. Brandt previously held the title of Executive Vice President, Clinical Research and Medical Affairs. Dr. Steven Quay will remain the Company's Chairman and Chief Executive Officer.

"We are pleased to promote Gordon to the position of President of Nastech as he has been instrumental in progressing our technologies and programs over the past five years and in his new role he will have increased responsibilities in our business relationships and operations. Gordon has been the architect in designing and conducting multiple development programs which will yield Phase 2 results in 2008," stated Steven C. Quay, M.D., Ph.D., Chairman and CEO of Nastech. "This move will position Gordon for more active leadership in Nastech and allows me to increase my efforts on establishing MDRNA as an independent company concentrating on the development of RNA-based therapeutics, which we believe will eventually provide greater focus for both companies and enhance shareholder value."

"Nastech has developed a strong clinical pipeline of innovative therapeutics using our proprietary drug delivery technologies which are aimed at providing patients with a safe and effective method of administering their medications without an injection," stated Gordon Brandt, M.D., President of Nastech. "I look forward to advancing our business imperatives and clinical programs in the therapeutic areas we have targeted including osteoporosis, diabetes, and obesity."

Dr. Brandt joined Nastech in November, 2002 serving as the Executive Vice President, Clinical Research and Medica
'/>"/>

SOURCE Nastech Pharmaceutical Company Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Nastech to Host 2007 Analyst and Institutional Investor Day
2. Nastech to Release Third Quarter Financial Results and Host Webcast on Monday, October 29, 2007
3. Nastech Announces Third Quarter 2007 Financial Results
4. Nastech to Present at Acumen BioFin Rodman & Renshaw Healthcare Conference
5. Nastech to Present at BMO Capital Markets Focus on Healthcare Conference
6. Nastech Enters Into Feasibility Study to Develop a Non-Injectable Dosage Form of Factor IX to Control Bleeding
7. Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc.
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall...Company") (OTC Bulletin Board: EMDY), a leading,pr...rmula, milk powder and,soybean products in China, ...in the Spring issue of US Food & Drink Executi... 250,000 executives in the food and beverage indus...
(Date:12/2/2009)... SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The worl...e in turmoil and uncertainty is part of many,busin... industry has been,relatively immune to the econom...on. , During the midst of the difficult t...amp; Johnson inaugurated an R&D center in Shan...
(Date:12/1/2009)... Dr. Kerry Solomon announced that he has...ed his redesigned website at www.DrKerrySolomon.c...up. Dr. Solomon is a proven LASIK, lens implant, ...nally recognized for his substantial contributions...member of Trusted LASIK Surgeons, which screens LA...
(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker.c...available in its catalogue: ,, Industrial Enzy...portlinker.com/p0164431/Industrial-Enzymes---A-Glo...arket is an oligopoly with few strong players and ...activities. Keen competition and commoditization c...
Breaking Biology Technology:Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
... Tovatech announces German-engineered Elmasonic ...in the laboratory: to clean parts, degas solvent, ... South Orange, NJ (PRWEB) No... Ultrasonic Cleaning Equipment for cleaning the w...metal, etc.) found in laboratory vessels and equip...
...IA Pharmaceuticals,Inc. (Nasdaq: VIAP ), a biotec...ounds for the treatment of cardiovascular disease,...at three upcoming investor conferences., The pre...aw Annual Global Investment Conference Wednesday,...Lazard Capital Markets Healthcare Conference Wedn...
... study success at Berlin conference, RALEIGH, N.C...esearch Organization announces it will present dur...4 - 7 November, 2008 in Berlin,Germany. PRA,s Chri...elopment - Europe, will present "What,s next in th...day, 5 November. Drawing on his extensive,experien...
Other Biology Technology:The Elmasonic S Ultrasonic Cleaner: Designed for the Scientific Laboratory 2The Elmasonic S Ultrasonic Cleaner: Designed for the Scientific Laboratory 3PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress 2
(Date:12/3/2009)...nimal species can be likened to emptying a museum ...tential medicines into the trash, or replacing eve...the decline of species and their habitats may not ...sts it may also put you at greater risk for catchi...d biodiversity loss,"driven by the replacement of ...
(Date:12/3/2009)...entists believe that staph infections are caused b...mit toxins. The signaling process is called quorum...start the process. , But the Jeff Brinker resear...of staph infection, when bacteria switch from a ha... and that this individual process can be stopped b...
(Date:12/3/2009)...ded in the design of the upcoming forest deal at C... according to a scientist at the University of Lee... argues that at least 50% of the carbon credit pay...educing Emissions from Deforestation and Degredati...nd their property rights assured. , "There is th...
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels 13502 1BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels 13502 2BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels 13502 3BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels 13502 4MinuteClinic Offers New Rapid Pink Eye Test 3B Detects Viral Conjunctivitis Infections in Minutes 54196 1MinuteClinic Offers New Rapid Pink Eye Test 3B Detects Viral Conjunctivitis Infections in Minutes 54196 2MinuteClinic Offers New Rapid Pink Eye Test 3B Detects Viral Conjunctivitis Infections in Minutes 54196 3Foundation Radiology Group Signs Exclusive Contract With Uniontown Hospital 54193 1Foundation Radiology Group Signs Exclusive Contract With Uniontown Hospital 54193 2
...y of Newcastle, England, and the Virginia Bioinfor...ates have revealed a large reservoir of mitochondr...n. Clinical analysis of blood samples from almost ...ed that at least 1 in 200 individuals in the gener...may lead to disease. The findings, which highlight...
...ner of the International Primatological Society (I... research and contributions to primatology. The aw...in Edinburgh, Scotland, on 7 August 2008. Nishida ...izing our understanding of ape and human evolution...h Jane Goodall. Nishida and Goodall are honored fo...
... than ever give breastfeeding a try, a new nationa...ng as they should. , Although 77 percent of moms ...ung University study found that only 36 percent of...rt of the federal government,s goal to hit 50 perc...ians recommends continued breastfeeding through th...
Other Biology News:Large reservoir of mitochondrial DNA mutations identified in humans 2Springer editor Toshisada Nishida winner of 2 prestigious primatology awards 2New breastfeeding study shows most moms quit early 2
Saponin from Calbiochem
Rabbit Anti-Autotaxin / ENPP2 Antibody, Unconjugated from Cosmo Bio Co., Ltd.
Streptozotocin from Calbiochem
Mouse Anti-Human CDC2L5 Monoclonal Antibody, Unconjugated, Clone 1B3-1B11 from Novus Biologicals
Biology Products: